Bioheart

Bioheart Biotechnology Co., Ltd., located in the Medical Device Industrial Park of Shanghai's Zhangjiang High-Tech Zone, is a leading Chinese company specializing in interventional cardiovascular devices. The company focuses on two therapies—Bioresorbable Scaffolds (BRS) and Renal Denervation (RDN)—to address unmet medical needs of Chinese patients suffering from coronary and peripheral artery diseases as well as hypertension. With a leased area of approximately 6,500 square meters, the company operates around 4,000 square meters of Class 10,000 cleanrooms and a comprehensive testing laboratory for related products. It has established a quality management system compliant with ISO13485/YY0287 standards and has gathered professionals specializing in mechanics, materials, precision processing, and clinical medicine. Additionally, the company boasts an experienced team proficient in product design, quality control, clinical validation, and market development.